Related Experiment Video
Updated: Oct 16, 2025
08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.0K
COVID-19: State of the Vaccination
Caroline Fenton1, Yvette N Lamb1
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754 New Zealand.
Drugs & Therapy Perspectives : for Rational Drug Selection and Use
|October 20, 2021
Summary
The COVID-19 pandemic spurred rapid vaccine development, with several candidates showing good efficacy. Global vaccine rollout faces challenges, and ongoing studies are monitoring long-term safety and immune responses.
Area of Science:
- * Virology and Immunology
- * Vaccine Technology and Development
Background:
- * The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic necessitated swift vaccine creation and emergency use (EU) authorization.
- * The World Health Organization has EU-listed six vaccines, including two novel mRNA vaccines, with more showing promising trial data.
Purpose of the Study:
- * To review the current landscape of COVID-19 vaccines.
- * To identify barriers to global vaccine accessibility and utilization.
- * To highlight the ongoing collection of long-term safety and immunogenicity data.
Main Methods:
- * Review of published clinical trial data for COVID-19 vaccines.
- * Analysis of World Health Organization emergency use listing criteria.
- * Monitoring of ongoing safety and immunogenicity studies.
Main Results:
- * Multiple COVID-19 vaccines demonstrate good efficacy.
- * Two mRNA vaccines are among the six WHO-listed EU vaccines.
- * Significant barriers impede the global distribution and use of vaccines.
Conclusions:
- * Despite high efficacy, global vaccine access remains a challenge.
- * Continued monitoring of long-term safety and immunogenicity is crucial.
- * Further research and strategic planning are needed to overcome rollout barriers.
More Related Videos
Related Concept Videos
01:51Vaccinations
46.3K
Overview
46.3K
01:29Contingency Table
2.7K
A contingency table provides a way of portraying data that can facilitate calculating probabilities. It is a method of displaying a frequency distribution as a table with rows and columns to show how two variables may be dependent (contingent) upon each other; The table helps determine conditional probabilities quite quickly and can help systematically organize, analyze and quantify data. The table displays sample values concerning two variables that may be dependent or contingent on one...
2.7K
01:30Cancer Vaccines
562
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
562
01:26Principles of Disease Surveillance
238
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
238
01:22Development of Immunocompetence
516
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
516
01:08Prevalence and Incidence
952
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
952